Search Results - "STILGENBAUER, F"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation by EMIG, R, MAGENER, A, EHEMANN, V, MEYER, A, STILGENBAUER, F, VOLKMANN, M, WALLWIENER, D, SINN, H.-P

    Published in British journal of cancer (01-12-1998)
    “…The p16 protein plays an important role in the transition of cells into the G1 phase of the cell cycle. We have studied the prevalence of p16 protein…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma by VOLKMANN, Martin, SCHIFF, Jan-H, HAJJAR, Yaser, OTTO, Gerd, STILGENBAUER, Franziska, FIEHN, Walter, GALLE, Peter R, HOFMANN, Walter J

    “…Experimental data have shown p53-dependent CD95 induction to be associated with increased levels of apoptosis after cytostatic treatment in hepatoma cells. A…”
    Get full text
    Journal Article
  6. 6

    CDKN2 mutation is infrequent in german hepatocellular carcinoma by Volkmann, M, Stilgenbauer, F, Hofmann, W J, Otto, G, Schiff, J H, Fiehn, W

    Published in Oncology (01-01-1999)
    “…For hepatocellular carcinoma, only scarce and controversial data on CDKN2 alterations are available. A high rate of mutations in a Chinese study contrasts with…”
    Get more information
    Journal Article
  7. 7
  8. 8